These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Splice variants of CD44 in human cervical cancer stage IB to IIB. Kainz C; Kohlberger P; Sliutz G; Tempfer C; Heinzl H; Reinthaller A; Breitenecker G; Koelbl H Gynecol Oncol; 1995 Jun; 57(3):383-7. PubMed ID: 7539775 [TBL] [Abstract][Full Text] [Related]
7. Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells. Fujita N; Yaegashi N; Ide Y; Sato S; Nakamura M; Ishiwata I; Yajima A Cancer Res; 1994 Jul; 54(14):3922-8. PubMed ID: 7518345 [TBL] [Abstract][Full Text] [Related]
8. Preferential overexpression of CD44v5 in advanced gastric carcinoma Goseki grades I and III. Stachura J; Krzeszowiak A; Popiela T; Urbańczyk K; Pituch-Noworolska A; Wieckiewicz J; Zembala M Pol J Pathol; 1999; 50(3):155-61. PubMed ID: 10624117 [TBL] [Abstract][Full Text] [Related]
9. A novel region of amplification at 11p12-13 in gastric cancer, revealed by representational difference analysis, is associated with overexpression of CD44v6, especially in early-onset gastric carcinomas. Carvalho R; Milne AN; Polak M; Offerhaus GJ; Weterman MA Genes Chromosomes Cancer; 2006 Oct; 45(10):967-75. PubMed ID: 16868940 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical localization of CD44 variants 5 and 6 in human gastric mucosa and gastric cancer. Mirecka J; Marx D; Schauer A Anticancer Res; 1995; 15(4):1459-65. PubMed ID: 7544568 [TBL] [Abstract][Full Text] [Related]
11. Alternative splicing of CD44 pre-mRNA in human colorectal tumors. Finn L; Dougherty G; Finley G; Meisler A; Becich M; Cooper DL Biochem Biophys Res Commun; 1994 Apr; 200(2):1015-22. PubMed ID: 7513991 [TBL] [Abstract][Full Text] [Related]
12. The immunohistochemical expression of E-cadherin in gastric cancer; correlations with clinicopathological factors and patients' survival. Lazăr D; Tăban S; Ardeleanu C; Dema A; Sporea I; Cornianu M; Lazăr E; Vernic C Rom J Morphol Embryol; 2008; 49(4):459-67. PubMed ID: 19050793 [TBL] [Abstract][Full Text] [Related]
13. CD44 isoform expression in primary and metastatic pancreatic adenocarcinoma. Rall CJ; Rustgi AK Cancer Res; 1995 May; 55(9):1831-5. PubMed ID: 7537174 [TBL] [Abstract][Full Text] [Related]
14. Abnormal retention of intron 9 in CD44 gene transcripts in human gastrointestinal tumors. Yoshida K; Bolodeoku J; Sugino T; Goodison S; Matsumura Y; Warren BF; Toge T; Tahara E; Tarin D Cancer Res; 1995 Oct; 55(19):4273-7. PubMed ID: 7545538 [TBL] [Abstract][Full Text] [Related]
15. New CD44 splice variants associated with human breast cancers. Iida N; Bourguignon LY J Cell Physiol; 1995 Jan; 162(1):127-33. PubMed ID: 7529235 [TBL] [Abstract][Full Text] [Related]
16. Nucleotide variants within the IQGAP1 gene in diffuse-type gastric cancers. Morris LE; Bloom GS; Frierson HF; Powell SM Genes Chromosomes Cancer; 2005 Mar; 42(3):280-6. PubMed ID: 15611933 [TBL] [Abstract][Full Text] [Related]
17. Frequent methylation of Vimentin in well-differentiated gastric carcinoma. Kitamura YH; Shirahata A; Sakata M; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K Anticancer Res; 2009 Jun; 29(6):2227-9. PubMed ID: 19528485 [TBL] [Abstract][Full Text] [Related]
18. Desmoglein 2 is expressed abnormally rather than mutated in familial and sporadic gastric cancer. Biedermann K; Vogelsang H; Becker I; Plaschke S; Siewert JR; Höfler H; Keller G J Pathol; 2005 Oct; 207(2):199-206. PubMed ID: 16025435 [TBL] [Abstract][Full Text] [Related]
19. Gastric cancer: correlation between clinicopathological factors and survival of patients. II. Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C Rom J Morphol Embryol; 2009; 50(2):185-94. PubMed ID: 19434309 [TBL] [Abstract][Full Text] [Related]